Suguru Imaeda, MD
Associate Professor; Director of Dermatology, Yale University Health Services, Dermatology; Director of Dermatology Service, Veteran Affairs Medical Center, Dermatology
Research & Publications
Biography
News
Coauthors
Selected Publications
- P099 LEUKOCYTOCLASTIC VASCULITIS AFTER USTEKINUMAB INDUCTION IN CROHN'S DISEASE: A CASE SERIES AND SYSTEMATIC REVIEWChugh R, Proctor D, Little A, Myung P, Imaeda S, Al-Bawardy B. P099 LEUKOCYTOCLASTIC VASCULITIS AFTER USTEKINUMAB INDUCTION IN CROHN'S DISEASE: A CASE SERIES AND SYSTEMATIC REVIEW. Gastroenterology 2020, 158: s3. DOI: 10.1053/j.gastro.2019.11.046.
- P099 LEUKOCYTOCLASTIC VASCULITIS AFTER USTEKINUMAB INDUCTION IN CROHN’S DISEASE: A CASE SERIES AND SYSTEMATIC REVIEWChugh R, Proctor D, Little A, Myung P, Imaeda S, Al-Bawardy B. P099 LEUKOCYTOCLASTIC VASCULITIS AFTER USTEKINUMAB INDUCTION IN CROHN’S DISEASE: A CASE SERIES AND SYSTEMATIC REVIEW. Inflammatory Bowel Diseases 2020, 26: s2-s2. DOI: 10.1093/ibd/zaa010.004.
- Cutaneous umbilical endometriosisWennerberg S, Imaeda S. Cutaneous umbilical endometriosis Journal of Dermatology for Physician Assistants. 2015, 9(1):26.
- Pneumocystis carinii pneumonia complicating methotrexate treatment of pityriasis rubra pilarisDuncan K, Imaeda S, Milstone L. Pneumocystis carinii pneumonia complicating methotrexate treatment of pityriasis rubra pilaris. Journal Of The American Academy Of Dermatology 1998, 39: 276-278. PMID: 9704846, DOI: 10.1016/s0190-9622(98)70088-x.
- Tumor‐specific peptides in cutaneous T‐cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T‐cell receptorBerger C, Longley B, Imaeda S, Christensen I, Heald P, Edelson R. Tumor‐specific peptides in cutaneous T‐cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T‐cell receptor. International Journal Of Cancer 1998, 76: 304-311. PMID: 9579563, DOI: 10.1002/(sici)1097-0215(19980504)76:3<304::aid-ijc3>3.0.co;2-z.
- The Evolution of Anti-Tumor ImmunotherapyImaeda S. The Evolution of Anti-Tumor Immunotherapy. Journal Of Investigative Dermatology 1997, 108: 695-697. PMID: 9129216, DOI: 10.1111/1523-1747.ep12292070.
- Induction of Functional Empty Class I Major Histocompatibility Complex Glycoproteins by Photoactivated 8-MethoxypsoralenImaeda S, Felli A, Schmitt I, Chimenti S, Edelson R. Induction of Functional Empty Class I Major Histocompatibility Complex Glycoproteins by Photoactivated 8-Methoxypsoralen. Journal Of Investigative Dermatology 1996, 107: 887-890. PMID: 8941680, DOI: 10.1111/1523-1747.ep12331193.
- Incorrect attribution of peptide sourceShepherd J, Schumacher T, Ashton-Rickardt P, Imaeda S, Ploegh H, Janeway C, Tonegawa S. Incorrect attribution of peptide source. Cell 1993, 75: 613. DOI: 10.1016/0092-8674(93)90482-6.
- TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selectiveShepherd J, Schumacher T, Ashton-Rickardt P, Imaeda S, Ploegh H, Janeway C, Tonegawa S. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 1993, 74: 577-584. PMID: 8348620, DOI: 10.1016/0092-8674(93)80058-m.
- Treatment of Multiple Apocrine Hidrocystomas with the Carbon Dioxide (CO2) LaserBICKLEY L, GOLDBERG D, IMAEDA S, Lambert W, SCHWARTZ R. Treatment of Multiple Apocrine Hidrocystomas with the Carbon Dioxide (CO2) Laser. Dermatologic Surgery 1989, 15: 599-602. PMID: 2723224, DOI: 10.1111/j.1524-4725.1989.tb03597.x.